138 related articles for article (PubMed ID: 10850350)
21. Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-alpha 2a.
Klein SB; Blatt LM; Taylor MW
J Interferon Res; 1993 Oct; 13(5):341-7. PubMed ID: 8301154
[TBL] [Abstract][Full Text] [Related]
22. From cloning to a commercial realization: human alpha interferon.
Baron E; Narula S
Crit Rev Biotechnol; 1990; 10(3):179-90. PubMed ID: 2268870
[TBL] [Abstract][Full Text] [Related]
23. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
24. Antibodies against IFN gamma-binding proteins recognize a member of IFN alpha R complex.
Bello I; Rodes L; Saura PL
Biochem Biophys Res Commun; 2001 Feb; 280(4):1197-202. PubMed ID: 11162654
[TBL] [Abstract][Full Text] [Related]
25. The human interferon system: characterization and classification after discovery of novel members.
Kontsek P; Karayianni-Vasconcelos G; Kontseková E
Acta Virol; 2003; 47(4):201-15. PubMed ID: 15068375
[TBL] [Abstract][Full Text] [Related]
26. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
27. Alpha and beta interferons and their receptor and their friends and relations.
Uzé G; Lutfalla G; Mogensen KE
J Interferon Cytokine Res; 1995 Jan; 15(1):3-26. PubMed ID: 7648431
[No Abstract] [Full Text] [Related]
28. Molecular and biologic characterization of recombinant interferon-alpha2b.
Bordens R; Grossberg SE; Trotta PP; Nagabhushan TL
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-41-S9-51. PubMed ID: 9208872
[TBL] [Abstract][Full Text] [Related]
29. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
30. Interferon-alpha hybrids.
Horisberger MA; Di Marco S
Pharmacol Ther; 1995 Jun; 66(3):507-34. PubMed ID: 7494857
[TBL] [Abstract][Full Text] [Related]
31. Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors.
Oberg K; Alm GV
J Interferon Res; 1989 Sep; 9 Suppl 1():S45-9. PubMed ID: 2809277
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
Greiner JW; Fisher PB; Pestka S; Schlom J
Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
[TBL] [Abstract][Full Text] [Related]
33. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
Spiegel RJ; Jacobs SL; Treuhaft MW
J Interferon Res; 1989 Sep; 9 Suppl 1():S17-24. PubMed ID: 2553829
[TBL] [Abstract][Full Text] [Related]
34. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
35. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
[TBL] [Abstract][Full Text] [Related]
36. Anti-HIV-1 activity of recombinant and hybrid species of interferon-alpha.
Sperber SJ; Gocke DJ; Haberzettl C; Kuk R; Schwartz B; Pestka S
J Interferon Res; 1992 Oct; 12(5):363-8. PubMed ID: 1331260
[TBL] [Abstract][Full Text] [Related]
37. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
[TBL] [Abstract][Full Text] [Related]
38. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
Linkesch M; Kuzmits R; Geyer G
Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic alpha-interferons protein: structure, production, and biosimilar.
El-Baky NA; Redwan EM
Prep Biochem Biotechnol; 2015; 45(2):109-27. PubMed ID: 24785737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
